Skip to main content
logo
Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
8.49
-0.25 (-2.86%)
Nov 2, 2026, 4:00 PM EST - Market closed

Benitec Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
2964603076579
Market Cap Growth
-31.05%49.66%369.05%881.17%-29.60%-71.60%
Enterprise Value
1172762055212
Last Close Price
8.4913.3811.706.994.0519.72

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
----88.98129.85
PB Ratio
1.652.603.161.3933.043.29
P/TBV Ratio
1.672.603.161.3933.043.29

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
----9.9423.51

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.000.000.010.012.770.28
Net Debt / Equity Ratio
-1.01-1.01-1.00-1.07-9.49-1.13
Net Debt / EBITDA Ratio
3.513.512.322.260.100.18
Net Debt / FCF Ratio
10.7810.784.112.580.110.20
Asset Turnover
----0.010.01
Quick Ratio
33.6833.6854.2610.380.641.61
Current Ratio
34.0034.0054.6710.490.941.90
Return on Equity (ROE)
-33.21%-33.21%-52.46%-91.68%-1268.61%-159.08%
Return on Assets (ROA)
-22.67%-22.67%-34.39%-49.60%-228.53%-81.59%
Return on Capital Employed (ROCE)
-28.90%-28.90%-42.70%-47.60%-3926.10%-518.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-11.52%-9.91%-12.35%-33.22%-293.13%-192.09%
FCF Yield
-5.61%-3.62%-7.69%-29.91%-269.92%-167.86%
Buyback Yield / Dilution
-28.58%-28.58%-97.17%-1225.17%-188.30%-90.24%
SEC Filings: 10-K · 10-Q